BPWM
ABBV icon

BCS Private Wealth Management’s AbbVie ABBV Stock Holding History

BCS Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+900
New +$194K 0.07% 171
2026
Q1 		– Sell
-900
Closed -$206K – 187
2025
Q4 		$206K Hold
900
– – 0.07% 171
2025
Q3 		$208K Buy
+900
New +$183K 0.07% 155

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCS Private Wealth Management's ABBV Position: Q2 2026 in Review

BCS Private Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 900 shares worth $226K. The stake represents 0.07% of the portfolio and ranks #171 among its holdings. This is a return to the name: BCS Private Wealth Management previously reported a position in ABBV as recently as Q4 2025.

BCS Private Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BCS Private Wealth Management held 900 shares of AbbVie worth $226K as of Q2 2026.
  • AbbVie was a new BCS Private Wealth Management position in Q2 2026.
  • AbbVie made up 0.07% of BCS Private Wealth Management's portfolio in Q2 2026, its #171 holding.
  • BCS Private Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.